Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI118902

Long-lasting memory T cell responses following self-limited acute hepatitis B.

A Penna, M Artini, A Cavalli, M Levrero, A Bertoletti, M Pilli, F V Chisari, B Rehermann, G Del Prete, F Fiaccadori, and C Ferrari

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Penna, A. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Artini, M. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Cavalli, A. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Levrero, M. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Bertoletti, A. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Pilli, M. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Chisari, F. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Rehermann, B. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Del Prete, G. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Fiaccadori, F. in: JCI | PubMed | Google Scholar

Cattedra Malattie Infettive, Università di Parma, Italy.

Find articles by Ferrari, C. in: JCI | PubMed | Google Scholar

Published September 1, 1996 - More info

Published in Volume 98, Issue 5 on September 1, 1996
J Clin Invest. 1996;98(5):1185–1194. https://doi.org/10.1172/JCI118902.
© 1996 The American Society for Clinical Investigation
Published September 1, 1996 - Version history
View PDF
Abstract

The molecular and cellular basis of long-term T cell memory against viral antigens is still largely undefined. To characterize anti-viral protection by memory T cells against non-cytopathic viruses able to cause acute self-limited and chronic infections, such as the hepatitis B virus (HBV), we studied HLA class II restricted responses against HBV structural antigens in 17 patients with acute hepatitis B, during the acute stage of infection and 2.2 to 13 yr after clinical resolution of disease. Results indicate that: (a) significant T cell proliferative responses to HBV nucleocapsid antigens were detectable in all patients during the acute phase of infection and in 14/17 also 2-13 yr after clinical resolution of disease; b) long-lasting T cell responses were sustained by CD45RO+T cells, predominantly expressing the phenotype of recently activated cells; c) limiting dilution analysis showed that in some patients the frequency of HBV-specific T cells was comparable to that observed in the acute stage of infection and, usually, higher than in patients with chronic HBV infection; d) the same amino acid sequences were recognized by T cells in the acute and recovery phases of infection; and e) HBV-DNA was detectable by nested-PCR in approximately half of the subjects. to conclusion, our results show that vigorous anti-viral T cell responses are detectable in vitro several years after clinical recovery from acute hepatitis B. Detection of minute amounts of virus in some recovered subjects suggests that long-term maintenance of an active anti-viral T cell response could be important not only for protection against reinfection but also for keeping the persisting virus under tight control.

Version history
  • Version 1 (September 1, 1996): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts